Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Innovative Pharmaceutical Biotech ( (HK:0399) ) is now available.
Starcoin Group Limited has been notified by the Hong Kong Stock Exchange that it has failed to maintain sufficient operations and asset value to support its continued listing. As a result, trading of its shares is set to be suspended unless the company successfully appeals the decision. The company is preparing to request a review of this decision, but the outcome remains uncertain, prompting shareholders and potential investors to exercise caution.
More about Innovative Pharmaceutical Biotech
Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, is a company incorporated in the Cayman Islands and continued in Bermuda with limited liability. It operates in the pharmaceutical and biotech industry, focusing on innovative solutions and products within this sector.
Average Trading Volume: 15,389,517
Technical Sentiment Signal: Sell
Current Market Cap: HK$510M
Learn more about 0399 stock on TipRanks’ Stock Analysis page.